Validation Data Gallery
|Positive WB detected in||A431 cells, RAW 264.7 cells|
|Positive IP detected in||mouse skin tissue|
|Positive IHC detected in||human skin cancer tissue, human kidney tissue|
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
|Positive IF detected in||HepG2 cells|
|Western Blot (WB)||WB : 1:200-1:1000|
|Immunoprecipitation (IP)||IP : 0.5-4.0 ug for IP and 1:200-1:1000 for WB|
|Immunohistochemistry (IHC)||IHC : 1:50-1:500|
|Immunofluorescence (IF)||IF : 1:10-1:100|
|Sample-dependent, check data in validation data gallery|
12604-1-AP targets IFIT2 in WB, IP, IHC, IF,ELISA applications and shows reactivity with human, mouse samples.
|Tested Reactivity||human, mouse|
|Cited Reactivity||human, mouse|
|Host / Isotype||Rabbit / IgG|
|Immunogen||IFIT2 fusion protein Ag3283|
|Full Name||IFIT 2|
|Calculated molecular weight||484 aa, 56 kDa|
|Observed molecular weight||50-55 kDa|
|GenBank accession number||BC032839|
|Gene ID (NCBI)||3433|
|Purification Method||Antigen affinity purification|
|Storage Buffer||PBS with 0.02% sodium azide and 50% glycerol pH 7.3.|
|Storage Conditions||Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.|
IFIT2 belongs to the IFIT family. It contains 6 TPR repeats. IFIT genes comprise a large family with three (Ifit1, Ifit2, and Ifit3) and four (IFIT1, IFIT2, IFIT3, and IFIT5) members in mice and humans, respectively. IFIT proteins are produced in human body that are supposed to confer immunity against viral infection. These proteins are generally produced during viral infection, IFN treatment, and during pathogen recognition (Pathogen associated molecular pattern recognition) by immune system during infections.
|Product Specific Protocols|
|WB protocol for IFIT2 antibody 12604-1-AP||Download protocol|
|IHC protocol for IFIT2 antibody 12604-1-AP||Download protocol|
|IF protocol for IFIT2 antibody 12604-1-AP||Download protocol|
|IP protocol for IFIT2 antibody 12604-1-AP||Download protocol|
|Click here to view our Standard Protocols|
The histone chaperone HIRA promotes the induction of host innate immune defences in response to HSV-1 infection.
Wellcome Open Res
Cell Cycle Checkpoints Cooperate to Suppress DNA- and RNA-Associated Molecular Pattern Recognition and Anti-Tumor Immune Responses.
ISG15-dependent Activation of the RNA Sensor MDA5 and its Antagonism by the SARS-CoV-2 papain-like protease.
The Small t Antigen of JC Virus Antagonizes RIG-I-Mediated Innate Immunity by Inhibiting TRIM25's RNA Binding Ability.
J Clin Lab Anal
Super-enhancer-associated long noncoding RNA RP11-569A11.1 inhibited cell progression and metastasis by regulating IFIT2 in colorectal cancer.